Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Asan Medical Center
Moderate to severe ulcerative colitis patients admitted in Inflammatory Bowel Disease (IBD) center will be enrolled in this study. Eligible patients had active UC with a Mayo score of 6-12 points (moderate or severe disease activity). The investigators will evaluate whether CMV-specific cell-mediated immune response at admission will predict the risk of active cytomegalovirus infection (true pathogen versus bystander).
Age
16–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
moderate to severe UC require hospitalization
age 16 or more
agree with written informed consent
You may not be if
pregnancy
foreign
immunosuppressed patients
Clareo Health | Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis
